Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
571
datasets available to search
ShareScore release 0.9.0
Dataset results
571 results for “CLL”
Prognostic Role of Platelet _lymphocyte and Neutrophil _monocyte in CLL
ClinicalTrials.gov study NCT04811950. IPD Sharing: NO. Countries: 0. Publications: 1.
American Ginseng Extract in Preventing Respiratory Infection and in Reducing Antibiotic Use in Patients With CLL
ClinicalTrials.gov study NCT00752895. IPD Sharing: NO. Countries: 1. Publications: 0.
Study Examining the Combination of Revlimid (Lenalidomide)and Vidaza (Azacitidine) for Relapsed/Refractory CLL and SLL
ClinicalTrials.gov study NCT01241786. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT02533401. IPD Sharing: Not stated. Countries: 2. Publications: 0.
CHAIROS Study A Study of MabThera/Rituxan (Rituximab) Maintenance Therapy in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Naive to Chemotherapy
ClinicalTrials.gov study NCT02013817. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Trial of Alemtuzumab and Rituximab in Patients With Previously Untreated CLL
ClinicalTrials.gov study NCT00858117. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Alemtuzumab/Fludarabine for Relapsed/Refractory B-cell Chronic Lymphocytic Leukemia (B-CLL)
ClinicalTrials.gov study NCT00206726. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mosunetuzumab for CLL MRD Clearance
ClinicalTrials.gov study NCT07052695. IPD Sharing: YES. Countries: 1. Publications: 0.
Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00536341. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ibrutinib as Early Therapy in Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT03207555. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01466153. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Chlorambucil + Lenalidomide and Lenalidomide Maintenance in Untreated Elderly With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01403246. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Alternating Thalidomide and Lenalidomide Therapy Plus Rituximab (ThRiL) as Initial Treatment for Patients With CLL
ClinicalTrials.gov study NCT01125176. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Zanubrutinib, Obinutuzumab, and Sonrotoclax in Previously Untreated Patients With CLL or SLL
ClinicalTrials.gov study NCT06849713. IPD Sharing: YES. Countries: 1. Publications: 0.
Zanubrutinib and Venetoclax in CLL (ZANU-VEN)
ClinicalTrials.gov study NCT05168930. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT06073821. IPD Sharing: YES. Countries: 21. Publications: 0.
Intravenous BI 836826 in Combination With Ibrutinib in Relapsed/Refractory CLL Patients Who Have Been Pre-treated With at Least One Prior Line of Systemic Therapy, and Who Are Eligible for Treatment W
ClinicalTrials.gov study NCT02759016. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Study of IPH2201 (Monalizumab) With Ibrutinib in Relapsed, Refractory or Previously Untreated CLL
ClinicalTrials.gov study NCT02557516. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Umbralisib Plus Ublituximab (U2) in Progressive CLL After Novel Therapy
ClinicalTrials.gov study NCT04149821. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Assess the Efficacy and Safety of Ublituximab and Umbralisib in Participants With Chronic Lymphocytic Leukemia (CLL) Currently Treated With Ibrutinib, Acalabrutinib or Venetoclax
ClinicalTrials.gov study NCT04016805. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.